Sir H. N. Reliance Foundation Hospital launches Sepsis Cart
The hospital hosted a two-day event with top internal and external faculty and medical experts
The hospital hosted a two-day event with top internal and external faculty and medical experts
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
The product is being launched in August 2023
Take proper precautions and seek timely treatment!
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Subscribe To Our Newsletter & Stay Updated